Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
IART vs. MASI: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 03'rd Jun 2026
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Masimo (MASI). But which of these two stocks presents investors with the better value oppo
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
07:30am, Tuesday, 02'nd Jun 2026
PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer L
Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue?
10:16am, Friday, 29'th May 2026
Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
4 High-Growth GARP Stocks With Attractive PEG Ratios for 2026
04:01pm, Friday, 22'nd May 2026
These four GARP stocks combine discounted PEG ratios with strong growth potential, offering investors a balanced strategy for 2026.
Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Friday, 22'nd May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IART or MASI: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 18'th May 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or Masimo (MASI). But which of these two stocks presents investors with the b
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
10:50am, Monday, 18'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
06:03pm, Sunday, 17'th May 2026
Integra LifeSciences NASDAQ: IART is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer L
Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript
09:50pm, Tuesday, 12'th May 2026
Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
08:00am, Friday, 08'th May 2026
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Le
Integra (IART) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Thursday, 07'th May 2026
Integra (IART) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript
02:51pm, Tuesday, 05'th May 2026
Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript
Integra (IART) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Tuesday, 05'th May 2026
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates
08:27am, Tuesday, 05'th May 2026
Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.
Integra LifeSciences Announces Leadership Transition
06:00am, Tuesday, 05'th May 2026
Stuart Essig Appointed as Integra's Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer
